ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

January 31, 2010

Conditions
HIV Infections
Interventions
DRUG

Atripla

Open label once daily for oral administration to be taken on an empty stomach

DRUG

Kivexa plus Sustiva

Open label once daily for oral administration

Trial Locations (1)

CB21 6GT

Gilead Sciences, Granta Park, Cambridge

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY